The tech-heavy Nasdaq led Wall Street declines, hitting a six-week low after fresh economic data indicated a deterioration in consumer sentiment.
Read More Nasdaq touches over one-month low after weak consumer sentiment data
Tag: Eli Lilly
Tech rally drives S&P 500, Nasdaq to record highs; Powell comments in focus
Wall Street’s main indexes climbed on Wednesday, while investors awaited comments from Federal Reserve Chair Jerome Powell later in the day.
Read More Tech rally drives S&P 500, Nasdaq to record highs; Powell comments in focus
Nvidia surpasses $3.6 trillion market value after Trump win
Shares of Nvidia rallied to a record high on Thursday, making the chipmaker the first company in history to surpass a stock market value of $3.6 trillion.
Read More Nvidia surpasses $3.6 trillion market value after Trump win
Wall St little unchanged as investors await Fed cues
Markets have been choppy after the S&P 500 and the Nasdaq extended gains to an eighth straight session on Monday.
Read More Wall St little unchanged as investors await Fed cues
Wall Street extends rout, CrowdStrike slumps on global tech outage
Wall Street’s main indexes fell on Friday, while investors assessed the impact of a global cyber outage that knocked down CrowdStrike’s shares to an over two-month low.
Read More Wall Street extends rout, CrowdStrike slumps on global tech outage
Donanemab, Eli Lilly’s Early Alzheimer’s Disease Treatment Approved By FDA
Donanemab is a monoclonal antibody that the U.S. Food and Drug Administration (FDA) approved on Tuesday with the goal of slowing the progression of early-stage symptomatic Alzheimer’s disease.
Read More Donanemab, Eli Lilly’s Early Alzheimer’s Disease Treatment Approved By FDA